P

Inventor

REN ALBERT S

US18 patents
⚠️ This page may combine multiple inventors who share the name “REN ALBERT S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ARENA PHARM INC

13 patents
US7132426B2Nov 7, 2006

Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC56 citations95
US7838525B2Nov 23, 2010

Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC39 citations92
US7470699B2Dec 30, 2008

Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC41 citations92
US7625906B2Dec 1, 2009

Fused-aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto

ARENA PHARM INC11 citations83
US10272094B2Apr 30, 2019

5-HT2C receptor agonists and compositions and methods of use

ARENA PHARM INC1 citations73
US10058549B2Aug 28, 2018

Imidazo[1,2-α]pyridine derivatives as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto

ARENA PHARM INC4 citations73
US10392390B2Aug 27, 2019

5-HT2C receptor agonists and compositions and methods of use

ARENA PHARM INC6 citations72
US10836764B2Nov 17, 2020

5-HT2C receptor agonists and compositions and methods of use

ARENA PHARM INC2 citations71
US9676758B2Jun 13, 2017

1-heteroaryl-indoline-4-carboxamides as modulators of GPR52 useful for the treatment or prevention of disorders related thereto

ARENA PHARM INC3 citations66
US11395824B2Jul 26, 2022

5-HT2C receptor agonists and compositions and methods of use

ARENA PHARM INC0 citations62
US10624900B2Apr 21, 2020

5-HT2C receptor agonists and compositions and methods of use

ARENA PHARM INC1 citations62
US11608339B2Mar 21, 2023

5-HT2C receptor agonists and compositions and methods of use

ARENA PHARM INC0 citations60
US9365511B2Jun 14, 2016

Biphenyl-ethyl-pyrrolidine derivatives as histamine H3 receptor modulators for the treatment of cognitive disorders

ARENA PHARM INC0 citations51

PACIFIC WAVE IND INC

2 patents

JONES ROBERT M

2 patents

XIONG YIFENG

1 patent